BioMarin to Participate in Upcoming Investor Conferences
Live audio webcasts and limited-time archives of BioMarin’s conference remarks are expected to be available via its investor relations site in September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioMarin (BMRN) will present at several healthcare investor conferences in September 2026, including events hosted by Wells Fargo, Cantor, Citi and Morgan Stanley. Presentations take place between September 9 and 14, 2026, at specified times in Eastern Time.
Live audio webcasts and limited-time archives of BioMarin’s remarks will be accessible through the company’s investor relations website at https://investors.biomarin.com/. The company describes itself as a global rare disease biotechnology firm with nine commercial therapies and an active clinical and preclinical pipeline.
Details
News Market Reaction – BMRN
On Sep 2, the day this news came out, BMRN closed 3.32% above the previous close.
Data tracked by StockTitan Argus for the Sep 2 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Wells Fargo 21st Annual Healthcare Conference, September 9 at 3:00 pm EST
- Cantor Global Healthcare Conference 2026, September 10 at 10:20 am EST
- Citi's 2026 Biopharma Back to School Conference, September 10 at 1:00 pm EST
- Morgan Stanley 24th Annual Global Healthcare Conference, September 14 at 10:00 am EST
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
To learn more, please visit www.biomarin.com.
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-investor-conferences-302866797.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.